A radiopharmaceutical for pancreatic exocrine functional diagnosis: 62Zn-EDDA metabolism in pancreas.
The metabolic pathway of radioactive 62Zn-EDDA (ethylenediamine-N,N'-diacetic acid), in the exocrine pancreas was studied with respect to that of endogenous Zn. In pancreatic duct cannulated dog, the secretion of intravenously injected exogenous 62Zn into pancreatic juice increased under the stimulation of CCK-PZ (pancreatic protein secretion stimulating hormone), which closely correlated to endogenous Zn. Moreover, in pancreatic juice, 62Zn as well as endogenous Zn was selectively bound to Zn-metalloenzymes, carboxypeptidase A and B. These results demonstrated the close correlation between the endogenous and the exogenously-administered Zn (62Zn-EDDA), as well as the high availability of 62Zn-EDDA as a marker of pancreatic function for the follow up of carboxypeptidase metabolism.
D000818:Animals; D043424:Carboxypeptidase B; D002268:Carboxypeptidases / Q000378:metabolism; D043422:Carboxypeptidases A; D002766:Cholecystokinin / Q000494:pharmacology; D004285:Dogs; D004492:Edetic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D008297:Male; D010179:Pancreas / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000502:physiology; D010189:Pancreatic Juice / Q000378:metabolism; D011877:Radionuclide Imaging; D015032:Zinc / Q000378:metabolism
C026058:EDDA; D002766:Cholecystokinin; D004492:Edetic Acid; D002268:Carboxypeptidases; D043422:Carboxypeptidases A; D043424:Carboxypeptidase B; D015032:Zinc